Golden has been acquired by ComplyAdvantage.Read about it here ⟶

‌

US Patent 10774108 Compositions and methods for treating CNS disorders

Patent 10774108 was granted and assigned to SAGE Therapeutics on September, 2020 by the United States Patent and Trademark Office.

Overview Structured Data Issues Contributors Activity

Is a

Patent

Patent attributes

Patent Applicant

SAGE Therapeutics

Current Assignee

SAGE Therapeutics

Patent Jurisdiction

United States Patent and Trademark Office

Patent Number

107741080

Date of Patent

September 15, 2020

Patent Application Number

155313130

Date Filed

November 27, 2015

Patent Citations

‌

US Patent 10246482 Neuroactive steroids, compositions, and uses thereof

Patent Citations Received

‌

US Patent 12083131 Neuroactive steroids, compositions, and uses thereof

‌

US Patent 12060386 Compositions and methods for treating CNS disorders

‌

US Patent 11478485 Compositions and methods for treating CNS disorders

‌

US Patent 11337987 Compositions and methods for treating central nervous system disorders

‌

US Patent 11945836 Compositions and methods for treating CNS disorders

Patent Primary Examiner

‌

Barbara P Badio

No article content yet.

Timeline

No Timeline data yet.

Further Resources

Title

Author

Link

Type

Date

No Further Resources data yet.

References

Find more entities like US Patent 10774108 Compositions and methods for treating CNS disorders

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.

Open Query Tool

Access by API